Table 8.
Clinicopathological features of RECQL VUSs and non-mutated patients.
| VUS | Nonmutated | p | |
|---|---|---|---|
| Age | 0.374 | ||
| ≤40 | 11 (22.00%) | 386 (18.66%) | |
| >40 | 39 (78.00%) | 1,683 (81.34%) | |
| Histopathological types | <0.001 | ||
| Invasive ductal carcinoma | 44 (91.67%) | 1,676 (97.10%) | |
| Carcinoma in situ | 2 (4.17%) | 44 (2.55%) | |
| Other types | 2 (4.17%) | 6 (0.35%) | |
| Molecular subtyping | 0.037 | ||
| Luminal A | 5 (10.42%) | 155 (9.04%) | |
| Luminal B | 24 (50.00%) | 1,125 (65.64%) | |
| TNBC | 2 (4.17%) | 106 (6.18%) | |
| HER2+ | 17 (35.42%) | 328 (19.14%) | |
| Histologic staging | 0.870 | ||
| I | 9 (19.15%) | 334 (18.64%) | |
| II | 27 (57.45%) | 960 (53.57%) | |
| III | 9 (19.15%) | 434 (24.2%) | |
| unknown | 2 (4.26%) | 64 (3.57%) | |
| TNM | |||
| 0 | 2 (4.00%) | 205 (10.07%) | 0.083 |
| I | 10 (20.00%) | 566 (27.80%) | |
| II | 21 (42.00%) | 844 (41.45%) | |
| III | 10 (20.00%) | 250 (12.28%) | |
| IV | 5 (10.00%) | 69 (3.39%) | |
| unknown | 2 (4.00%) | 102 (5.01%) | |
| Tumor size | 0.983 | ||
| ≤2 cm | 26 (60.47%) | 1,030 (60.30%) | |
| >2 cm | 17 (39.53%) | 678 (39.70%) | |
| Lymphonodus | 0.520 | ||
| Positive | 36 (78.26%) | 1,490 (81.24%) | |
| Negative | 10 (21.74%) | 328 (17.88%) | |
| Unknown | 0 | 16 (0.87%) | |
| Family history of breast tumors | 0.002 | ||
| Yes | 19 (38.00%) | 420 (20.27%) | |
| No | 31 (62.00%) | 1,652 (79.73%) | |
| Family history of other tumors | 0.034 | ||
| Yes | 26 (52.00%) | 773 (37.31%) | |
| No | 24 (48.00%) | 1,299 (62.69%) | |
| Distant metastasis | 0.838 | ||
| Yes | 3 (6.00%) | 159 (7.64%) | |
| No | 47 (94.00%) | 1922 (92.36%) |